Healthcare
•3759 stocks
•
Total Market Cap: Loading...
Price Performance Heatmap
5Y Price (Market Cap Weighted)
All Stocks (3759)
| Company | Market Cap | Price |
|---|---|---|
|
ALZN
Alzamend Neuro, Inc.
ALZN002 employs autologous dendritic cell–based therapy, a cell therapy modality.
|
$6.49M |
$2.25
+4.91%
|
|
KPRX
Kiora Pharmaceuticals, Inc.
Company's pipeline focuses on ophthalmic therapeutics (KIO-301, KIO-104) targeting retinal degenerative diseases and retinal inflammation, i.e., Ophthalmic Drugs.
|
$6.45M |
$1.89
+4.72%
|
|
KALA
KALA BIO, Inc.
KPI-012 is a mesenchymal stem cell secretome (MSC-S) therapy, aligning with Biotech - Cell Therapy.
|
$6.39M |
$0.94
+47.19%
|
|
SBFM
Sunshine Biopharma, Inc.
SBFM's Nora Pharma operates a growing Canadian generic prescription drug business.
|
$6.38M |
$1.42
+1.80%
|
|
SNGX
Soligenix, Inc.
ThermoVax vaccine thermostabilization platform and RiVax vaccine program place Soligenix in Vaccines.
|
$6.30M |
$1.48
+4.61%
|
|
MODV
ModivCare Inc.
MODV delivers technology-enabled healthcare services (NEMT, PCS, Monitoring) and related care operations, aligning with Healthcare Services & Facilities.
|
$6.19M |
$0.43
|
|
ADXN
Addex Therapeutics Ltd
Addex's core product category is oral small-molecule therapeutics (allosteric modulators including GABAB PAMs and mGluR modulators).
|
$6.14M |
$7.73
+5.89%
|
|
EVAX
Evaxion Biotech A/S
Evaxion develops vaccines, including EVX-01 for cancer and multiple infectious-disease vaccine programs.
|
$6.11M |
$5.68
+5.19%
|
|
INBS
Intelligent Bio Solutions Inc.
INBS directly develops and sells the Intelligent Fingerprinting Platform, a diagnostic device for non-invasive drug screening (fingerprint sweat-based testing) and associated cartridges/readers.
|
$6.02M |
$0.68
+2.89%
|
|
ACXP
Acurx Pharmaceuticals, Inc.
Lead product ibezapolstat is an oral small-molecule antibiotic for CDI, aligning with the 'Oral Small Molecule Therapeutics' investable theme.
|
$5.94M |
$3.75
-2.97%
|
|
NBY
NovaBay Pharmaceuticals, Inc.
Directly manufactures wound care devices which are the sole continuing reportable product line (export to China).
|
$5.94M |
$1.02
+8.50%
|
|
BZYR
Burzynski Research Institute, Inc.
Company focuses on oncology therapeutics in biotech R&D.
|
$5.78M |
$0.04
|
|
LYRA
Lyra Therapeutics, Inc.
XTreo drug-delivery platform is Lyra's core product, enabling six months of localized drug therapy via in-office implant (LYR-210).
|
$5.76M |
$3.56
+23.61%
|
|
SYNX
Silynxcom Ltd.
Vital signs monitoring headset positions the product within medical devices/biometric sensing.
|
$5.73M |
$1.00
-4.76%
|
|
ALBT
Avalon GloboCare Corp.
KetoAir breathalyzer is a directly produced diagnostic equipment device sold as a precision diagnostic product.
|
$5.71M |
$1.49
+10.37%
|
|
SSKN
STRATA Skin Sciences, Inc.
STRATA's core offerings are dermatology-focused excimer laser systems and related medical devices (XTRAC, Pharos lasers; VTRAC lamp systems; TheraClear X), which are medical devices and equipment.
|
$5.67M |
$1.39
+0.58%
|
|
PMCB
PharmaCyte Biotech, Inc.
PMCB develops oncology-focused cell-based therapies (Cell-in-a-Box encapsulation) aligned with Biotech - Oncology.
|
$5.65M |
$0.84
-5.92%
|
|
SXTC
China SXT Pharmaceuticals, Inc.
SXTC manufactures TCMP products and operates GMP-compliant production lines, consistent with a contract manufacturing organization (CMO) model.
|
$5.55M |
$1.41
|
|
AMIX
Autonomix Medical, Inc. Common Stock
Core platform is a catheter-based Neuromodulation Device designed to sense and ablate peripheral nerves.
|
$5.45M |
$1.07
+11.23%
|
|
BUDZ
WEED, Inc.
Sangre AgroTech represents plant genomic research services, akin to contract research and development.
|
$5.44M |
$0.04
|
|
GBCS
Selectis Health, Inc.
Operational healthcare facilities providing in-patient care aligns with Hospital Services as a proxy for healthcare facility operations.
|
$5.35M |
$1.75
|
|
SNOA
Sonoma Pharmaceuticals, Inc.
Company offers HOCl-based wound care products that function as wound care solutions/devices.
|
$5.32M |
$3.29
+0.61%
|
|
CPHI
China Pharma Holdings, Inc.
Core product: generic drugs manufacturing (Helpson's portfolio in PRC).
|
$5.32M |
$1.65
-0.30%
|
|
IBO
Impact BioMedical Inc.
Linebacker is an oncology-focused platform of electrophilically enhanced polyphenol compounds licensed for development and commercialization.
|
$5.24M |
$0.44
+1.14%
|
|
QNRX
Quoin Pharmaceuticals, Ltd.
Lead program targets a rare disease (Netherton Syndrome) and is developed by a biotech focused on rare diseases.
|
$5.23M |
$20.87
-6.41%
|
|
CDIO
Cardio Diagnostics Holdings, Inc.
Provides laboratory testing services and advisory support for diagnostics.
|
$5.18M |
$3.23
+10.24%
|
|
HSCS
HeartSciences Inc.
HeartSciences develops medical devices (wavECG) and biometric sensing capabilities, aligning with Medical Devices & Biometrics.
|
$5.16M |
$2.63
-6.23%
|
|
ADMT
ADM Tronics Unlimited, Inc.
Company designs and manufactures medical devices and biometric sensing technologies including diagnostics and therapeutics.
|
$5.14M |
$0.11
|
|
CYCN
Cyclerion Therapeutics, Inc.
Cyclerion is centered on neuropsychiatric drug development, specifically an individualized therapy for Treatment Resistant Depression (TRD).
|
$5.07M |
$1.53
+4.42%
|
|
LQMT
Liquidmetal Technologies, Inc.
Medical Device Components: Liquidmetal designs/manufactures customized components for medical devices using its amorphous alloys.
|
$4.84M |
$0.13
|
|
BTCY
Biotricity, Inc.
Core cardiology device portfolio including 3-channel ECG monitoring platforms (Bioflux/Biocore/Biocore Pro).
|
$4.64M |
$0.45
|
|
ENTO
Entero Therapeutics, Inc.
Adrulipase is a recombinant lipase enzyme produced as a therapeutic for exocrine pancreatic insufficiency, fitting Recombinant Proteins & Enzymes.
|
$4.51M |
$2.85
+2.33%
|
|
XWEL
XWELL, Inc.
XWEL's XpresTest program represents laboratory testing and advisory services, anchored by CDC collaborations and pathogen surveillance.
|
$4.37M |
$0.78
+2.41%
|
|
XTLB
XTL Biopharmaceuticals Ltd.
Core focus on autoimmune immunology therapeutics with lead asset hCDR1.
|
$4.33M |
$0.82
+4.72%
|
|
HSDT
Solana Company
PoNS is a non-invasive neuromodulation device produced by the company for gait and balance rehabilitation.
|
$4.32M |
$4.01
+11.70%
|
|
POAI
Predictive Oncology Inc.
Biotech - Oncology focus via proprietary biobank, wet-lab validation, and AI-enabled oncology drug discovery.
|
$4.28M |
$5.95
-0.50%
|
|
SILO
Silo Pharma, Inc.
Drug Delivery Platforms directly describes Silo's intranasal and implantable drug delivery technologies (SPC-15, SPC-14, SP-26).
|
$4.23M |
$0.46
+5.42%
|
|
TTNP
Titan Pharmaceuticals, Inc.
Titan's core ProNeura technology is a long-acting drug delivery platform used for subdermal implants.
|
$4.21M |
$4.61
|
|
APVO
Aptevo Therapeutics Inc.
APVO is a oncology-focused biotech developing novel immunotherapies, including mipletamig and other pipelines targeting cancer.
|
$4.21M |
$1.28
+7.08%
|
Showing page 36 of 38 (3759 total stocks)
Loading company comparison...
Loading industry trends...
Loading research report...
